Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis.
Pardanani A; Gotlib JR; Jamieson C; Cortes JE; Talpaz M; Stone RM; Silverman MH; Gilliland DG; Shorr J; Tefferi A; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2011, vol. 29, issue 7, p 789, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef